Literature DB >> 20717763

Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signal-transduction mechanisms.

Zhan Liu1, Yi-Hua Qiu, Bing Li, Song-Hua Ma, Yu-Ping Peng.   

Abstract

We have previously shown that interleukin-6 (IL-6)-protected neurons against the suppression of neuronal vitality and overload of intracellular Ca(2+) induced by glutamate or N-methyl-D: -aspartate (NMDA). Herein we provide further evidence for IL-6 neuroprotection against NMDA-induced apoptosis and explore the signal-transduction mechanisms underlying the anti-apoptotic action of IL-6. Cerebellar granule neurons (CGNs) from postnatal 8-day infant rats were chronically exposed to IL-6 (40 or 120 ng/ml) for 8 days, and stimulated with NMDA (100 μM) for 30 min. To observe the signaling pathways, we employed AG490 (5 or 10 μM), an inhibitor of Janus kinases (JAKs), or LY294002 (5 or 10 μM), an inhibitor of phosphatidylinositol 3-kinase (PI3K), to pretreat the CGNS together with IL-6. The levels of phosphorylation for the downstream effectors of JAKs and PI3K, i.e., phosphorylated STAT3 and Akt, were quantified by Western blot assay. In the cultured CGNs with various drug exposures, the expressions of Bcl-2, Bax, and caspase-3 were measured by real-time PCR and Western blot, and the percentage of apoptotic nuclei was tested by Hoechst 33342 staining. After the CGNs were chronically exposed to IL-6, NMDA stimulation led to an increase in the expression of Bcl-2 mRNA and a decrease in the expression of Bax and caspase-3 mRNAs and proteins when compared with those neurons lacking IL-6 exposure. IL-6 pretreatment of the neurons without NMDA stimulation concentration-dependently enhanced the expressions of Bcl-2 mRNA and protein while attenuating the expressions of Bax and caspase-3 mRNAs and proteins in comparison with control lacking any treatment. Furthermore, IL-6 prevented the increase in the percentage of apoptotic neurons induced by NMDA. The combined pretreatment of the CGNs with AG490 and IL-6 or with LY294002 and IL-6 reduced these anti-apoptotic effects of IL-6. Neither AG490 nor LY294002 exposure alone altered the expressions of Bcl-2, Bax, and cleaved caspase-3 proteins. IL-6 up-regulated the levels of phosphorylated STAT3 and Akt, and this was blocked by AG490 and LY294002, respectively. These results suggest that IL-6 protects neurons against NMDA-induced apoptosis, and that the IL-6 neuroprotection is jointly mediated by JAK-STAT3 and PI3K-Akt signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717763     DOI: 10.1007/s12640-010-9215-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  46 in total

1.  A first insight into the molecular mechanisms of apoptosis.

Authors:  Junying Yuan; H Robert Horvitz
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  BCL-2 family: regulators of cell death.

Authors:  D T Chao; S J Korsmeyer
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  Use of Hoechst 33342 staining to detect apoptotic changes in bovine mononuclear phagocytes infected with Mycobacterium avium subsp. paratuberculosis.

Authors:  S Allen; J Sotos; M J Sylte; C J Czuprynski
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

Review 4.  IL-6 signal transduction and its physiological roles: the signal orchestration model.

Authors:  D Kamimura; K Ishihara; T Hirano
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-04-05       Impact factor: 5.545

5.  Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.

Authors:  C Lütticken; U M Wegenka; J Yuan; J Buschmann; C Schindler; A Ziemiecki; A G Harpur; A F Wilks; K Yasukawa; T Taga
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

6.  Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures.

Authors:  Shannon M Conroy; Vi Nguyen; Lely A Quina; Penney Blakely-Gonzales; Christina Ur; Jeffrey G Netzeband; Anne L Prieto; Donna L Gruol
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

7.  Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons.

Authors:  Z Qiu; D D Sweeney; J G Netzeband; D L Gruol
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

8.  Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK.

Authors:  Xiao-Qin Wang; Yu-Ping Peng; Jian-Hua Lu; Bei-Bei Cao; Yi-Hua Qiu
Journal:  Neurosci Lett       Date:  2008-11-27       Impact factor: 3.046

9.  Apoptotic cell death induced by beta-amyloid 1-42 peptide is cell type dependent.

Authors:  M Gschwind; G Huber
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

10.  Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons.

Authors:  Zhihua Qiu; Donna L Gruol
Journal:  J Neuroimmunol       Date:  2003-06       Impact factor: 3.478

View more
  18 in total

1.  Glial responses to implanted electrodes in the brain.

Authors:  Joseph W Salatino; Kip A Ludwig; Takashi D Y Kozai; Erin K Purcell
Journal:  Nat Biomed Eng       Date:  2017-11-10       Impact factor: 25.671

2.  Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.

Authors:  Xiao-Xia Fang; Xiao-Lin Jiang; Xin-Hua Han; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Cell Mol Neurobiol       Date:  2012-11-16       Impact factor: 5.046

3.  Mesenchymal stromal cells rescue cortical neurons from apoptotic cell death in an in vitro model of cerebral ischemia.

Authors:  Franziska Scheibe; Oliver Klein; Joachim Klose; Josef Priller
Journal:  Cell Mol Neurobiol       Date:  2012-05       Impact factor: 5.046

4.  Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.

Authors:  K Szabadfi; T Atlasz; P Kiss; B Danyadi; A Tamas; Zs Helyes; H Hashimoto; N Shintani; A Baba; G Toth; R Gabriel; D Reglodi
Journal:  Neurotox Res       Date:  2011-06-30       Impact factor: 3.911

5.  The role of JAK-3 in regulating TLR-mediated inflammatory cytokine production in innate immune cells.

Authors:  Huizhi Wang; Jonathan Brown; Shegan Gao; Shuang Liang; Ravi Jotwani; Huaxin Zhou; Jill Suttles; David A Scott; Richard J Lamont
Journal:  J Immunol       Date:  2013-06-24       Impact factor: 5.422

6.  Interleukin-6 inhibits L-type calcium channel activity of cultured cerebellar granule neurons.

Authors:  Song-Hua Ma; Bing Li; Hui-Wei Huang; Yu-Ping Peng; Yi-Hua Qiu
Journal:  J Physiol Sci       Date:  2012-06-14       Impact factor: 2.781

7.  Targeting neurotensin as a potential novel approach for the treatment of autism.

Authors:  Ahmad Ghanizadeh
Journal:  J Neuroinflammation       Date:  2010-10-01       Impact factor: 8.322

Review 8.  Brain-immune interactions in perinatal hypoxic-ischemic brain injury.

Authors:  Bo Li; Katherine Concepcion; Xianmei Meng; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2017-10-27       Impact factor: 11.685

9.  Gastric vagal afferent modulation by leptin is influenced by food intake status.

Authors:  Stephen J Kentish; Tracey A O'Donnell; Nicole J Isaacs; Richard L Young; Hui Li; Andrea M Harrington; Stuart M Brierley; Gary A Wittert; L Ashley Blackshaw; Amanda J Page
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

10.  Bilateral elevation of interleukin-6 protein and mRNA in both lumbar and cervical dorsal root ganglia following unilateral chronic compression injury of the sciatic nerve.

Authors:  Petr Dubový; Václav Brázda; Ilona Klusáková; Ivana Hradilová-Svíženská
Journal:  J Neuroinflammation       Date:  2013-05-01       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.